Medical Data Vision Co., Ltd. (TYO:3902)
1,691.00
+1.00 (0.06%)
Jan 23, 2026, 3:30 PM JST
Medical Data Vision Balance Sheet
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Cash & Equivalents | 1,708 | 1,347 | 3,218 | 2,264 | 3,221 | 3,194 | Upgrade |
Cash & Short-Term Investments | 1,708 | 1,347 | 3,218 | 2,264 | 3,221 | 3,194 | Upgrade |
Cash Growth | -8.71% | -58.14% | 42.14% | -29.71% | 0.84% | 8.49% | Upgrade |
Receivables | 864.86 | 977 | 1,103 | 965 | 1,056 | 866 | Upgrade |
Inventory | 25.16 | 9 | 6 | 13 | 11 | 34 | Upgrade |
Prepaid Expenses | - | 345 | - | - | - | - | Upgrade |
Other Current Assets | 508.03 | 433 | 335 | 282 | 237 | 225 | Upgrade |
Total Current Assets | 3,106 | 3,111 | 4,662 | 3,524 | 4,525 | 4,319 | Upgrade |
Property, Plant & Equipment | 200.52 | 238 | 158 | 137 | 140 | 177 | Upgrade |
Long-Term Investments | 455.04 | 865 | 965 | 651 | 333 | 290 | Upgrade |
Goodwill | 44.95 | 64 | 89 | 257 | 222 | 294 | Upgrade |
Other Intangible Assets | 0.2 | - | 1 | 2 | 5 | 9 | Upgrade |
Long-Term Deferred Tax Assets | - | 383 | 344 | 324 | 308 | 231 | Upgrade |
Other Long-Term Assets | 780.19 | 2 | 2 | 2 | 1 | 1 | Upgrade |
Total Assets | 4,587 | 4,749 | 6,221 | 4,897 | 5,534 | 5,321 | Upgrade |
Accounts Payable | 224.69 | 218 | 140 | 93 | 97 | 76 | Upgrade |
Accrued Expenses | 31.73 | - | 5 | 4 | 28 | 78 | Upgrade |
Current Income Taxes Payable | 14.35 | 343 | 478 | 95 | 400 | 298 | Upgrade |
Current Unearned Revenue | 1,004 | - | - | - | 353 | 323 | Upgrade |
Other Current Liabilities | 257.78 | 877 | 1,182 | 1,014 | 365 | 324 | Upgrade |
Total Current Liabilities | 1,533 | 1,438 | 1,805 | 1,206 | 1,243 | 1,099 | Upgrade |
Long-Term Deferred Tax Liabilities | - | 5 | - | - | - | - | Upgrade |
Other Long-Term Liabilities | 156.61 | 154 | 100 | 85 | 86 | 86 | Upgrade |
Total Liabilities | 1,689 | 1,597 | 1,905 | 1,291 | 1,329 | 1,185 | Upgrade |
Common Stock | 992.66 | 992 | 992 | 992 | 992 | 992 | Upgrade |
Additional Paid-In Capital | 1,787 | 1,838 | 1,838 | 1,838 | 1,763 | 1,763 | Upgrade |
Retained Earnings | 2,565 | 2,756 | 3,795 | 3,045 | 2,879 | 1,934 | Upgrade |
Treasury Stock | -2,495 | -2,494 | -2,341 | -2,341 | -1,479 | -590 | Upgrade |
Comprehensive Income & Other | 19.69 | 7 | -33 | -18 | 1 | 1 | Upgrade |
Total Common Equity | 2,870 | 3,099 | 4,251 | 3,516 | 4,156 | 4,100 | Upgrade |
Minority Interest | 27.77 | 53 | 65 | 90 | 49 | 36 | Upgrade |
Shareholders' Equity | 2,898 | 3,152 | 4,316 | 3,606 | 4,205 | 4,136 | Upgrade |
Total Liabilities & Equity | 4,587 | 4,749 | 6,221 | 4,897 | 5,534 | 5,321 | Upgrade |
Net Cash (Debt) | 1,708 | 1,347 | 3,218 | 2,264 | 3,221 | 3,194 | Upgrade |
Net Cash Growth | -8.71% | -58.14% | 42.14% | -29.71% | 0.84% | 8.49% | Upgrade |
Net Cash Per Share | 45.12 | 35.30 | 84.25 | 59.21 | 82.19 | 80.84 | Upgrade |
Filing Date Shares Outstanding | 37.86 | 37.86 | 38.2 | 38.2 | 38.2 | 39.43 | Upgrade |
Total Common Shares Outstanding | 37.86 | 37.86 | 38.2 | 38.2 | 38.96 | 39.43 | Upgrade |
Working Capital | 1,573 | 1,673 | 2,857 | 2,318 | 3,282 | 3,220 | Upgrade |
Book Value Per Share | 75.81 | 81.86 | 111.29 | 92.05 | 106.67 | 103.99 | Upgrade |
Tangible Book Value | 2,825 | 3,035 | 4,161 | 3,257 | 3,929 | 3,797 | Upgrade |
Tangible Book Value Per Share | 74.61 | 80.17 | 108.94 | 85.27 | 100.85 | 96.31 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.